Why High Starch And Sugar Diets Drive Insulin Resistance And Chronic Disease

<p>This episode is brought to you by <a href="http://www.rupahealth.com/" rel="noopener noreferrer" target="_blank">Rupa Health</a>, <a href="http://www.paleovalley.com/hyman" rel="noopener noreferrer" target="_blank">Paleovalley</a>, and <a href="http://myessentia.com/drmarkhyman" rel="noopener noreferrer" target="_blank">Essentia</a>.</p><p>&nbsp;</p><p>The leading cause of inflammation is a poor diet—specifically one rich in addictive starches and refined sugars that keep us eating more than we need to because they don’t fill us up. This standard American diet (SAD) of refined flour and sugar is the gateway to insulin resistance, diabetes, and other metabolic issues, which cause rapid aging and chronic disease.</p><p>&nbsp;</p><p>In today’s episode, I talk with Dhru Purohit, Gary Taubes, and Dr. Ronesh Sinha about why we need to ditch the high-starch diet if we want to improve our metabolism and reduce chronic disease.</p><p>&nbsp;</p><p>Dhru Purohit is a podcast host, serial entrepreneur, and investor in the health and wellness industry. His podcast, <em>The Dhru Purohit Podcast</em>, is a top 50 global health podcast with over 30 million unique downloads. His interviews focus on the inner workings of the brain and the body and feature the brightest minds in wellness, medicine, and mindset.</p><p>&nbsp;</p><p>⁣Gary Taubes is an award-winning science and health journalist and cofounder and director of the Nutrition Science Initiative. He is the author of <em>The Case Against Sugar</em>, <em>Why We Get Fat</em>, <em>Good Calories, Bad Calories</em>, and <em>The Case for Keto</em>. Gary is a former staff writer for <em>Discover</em> and a correspondent for <em>Science</em>. He has written three cover articles on nutrition and health for <em>The New York Times Magazine</em>.</p><p>&nbsp;</p><p>Dr. Ronesh Sinha, author of <em>The South Asian Health Solution</em>, is an internal medicine physician who runs a lifestyle clinic in Silicon Valley focused on reversing insulin resistance in ethnically diverse patients. H